2022 (v1)
Publication
Focal adhesion kinase (FAK) is a non‐receptor tyrosine kinase over‐expressed in different solid cancers. In recent years, FAK has been recognized as a new target for the development of antitumor agents, useful to contrast tumor development and metastasis formation. To date, studies on the role of FAK and FAK inhibitors are of great interest for...
Uploaded on: April 14, 2023